Bcell Design Overview
- Year Founded
-
2007
- Status
-
Acquired/Merged
- Employees
-
5
- Latest Deal Type
-
M&A
- Financing Rounds
-
7
Bcell Design General Information
Description
Operator of a biotechnology company focused on developing therapeutic products intended for the pharmaceutical industry. The company's products include vaccines and immunotherapies for infectious diseases like human immunodeficiency virus (HIV) and different types of cancers, helping clients prevent infectious diseases and cancer.
Contact Information
Website
www.b-cell-design.com(Operating Subsidiary)
Corporate Office
- 850 boulevard Sébastien Brant
- 67400 Illkirch-Graffenstaden
- France
Corporate Office
- 850 boulevard Sébastien Brant
- 67400 Illkirch-Graffenstaden
- France
Bcell Design Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Bcell Design Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Bcell Design Patents
Bcell Design Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-11427646-B2 | Antibodies against carcinoembryonic antigen for cancer therapy and diagnosis | Active | 04-May-2017 | 00000000000 | 0 |
| EP-3619237-A1 | Antibodies against carcinoembryonic antigen for cancer therapy and diagnosis | Active | 04-May-2017 | 00000000000 | |
| US-20200055952-A1 | Antibodies against carcinoembryonic antigen for cancer therapy and diagnosis | Active | 04-May-2017 | 00000000000 | |
| EP-3398967-A1 | Antibodies against carcinoembryonic antigen for cancer therapy and diagnosis | Inactive | 04-May-2017 | 00000000000 | 0 |
| AU-2018262648-A1 | Antibodies against carcinoembryonic antigen for cancer therapy and diagnosis | Active | 04-May-2017 | C07K16/3007 |
Bcell Design Executive Team (5)
| Name | Title | Board Seat |
|---|---|---|
| Armelle Cuvillier Ph.D | Co-Founder | |
| Pierre Eftekhari Ph.D | Chief Executive Officer | |
| Jean-Christophe Peter Ph.D | Chief Scientific Officer |
Bcell Design Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Bcell Design Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Bcell Design FAQs
-
When was Bcell Design founded?
Bcell Design was founded in 2007.
-
Who is the founder of Bcell Design?
Armelle Cuvillier Ph.D is the founder of Bcell Design.
-
Who is the CEO of Bcell Design?
Pierre Eftekhari Ph.D is the CEO of Bcell Design.
-
Where is Bcell Design headquartered?
Bcell Design is headquartered in Illkirch-Graffenstaden, France.
-
What is the size of Bcell Design?
Bcell Design has 5 total employees.
-
What industry is Bcell Design in?
Bcell Design’s primary industry is Drug Discovery.
-
Is Bcell Design a private or public company?
Bcell Design is a Private company.
-
What is Bcell Design’s current revenue?
The current revenue for Bcell Design is 000000.
-
How much funding has Bcell Design raised over time?
Bcell Design has raised $2.09M.
-
Who are Bcell Design’s investors?
Fonds Strategique d'Investissement, Limousin Business Angels, Limousin Participations, and OSEO Innovation have invested in Bcell Design.
-
When was Bcell Design acquired?
Bcell Design was acquired on 04-Nov-2021.
-
Who acquired Bcell Design?
Bcell Design was acquired by Inoviem Scientific.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
